IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Botanical and Plant-Derived Drug Industry to Blossom

12:51 PM MST | February 27, 2009 | DEEPTI RAMESH

The global botanical and plant-derived drug market is expected to blossom by 2013, reaching a combined total of $32.9 billion a compound annual growth rate (CAGR) of 11%, according to a new study by BCC Research (Wellesley, MA). That is an increase from $19.5 billion last year, it adds Botanical drugs are those that are FDA approved under the botanical drug pathway; plant-derived drugs are those under a new FDA classification that are botanicals and contain a mixture of plant-derived and synthetic substances, BCC says. The plant-derived drug sector commands the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa